Abstract:Extracellular micro- and nanoscale membrane vesicles produced by different cells progressively attract the attention of the scientific community. They function as mediators of intercellular communication and transport genetic material and signaling molecules between the cells. In the context of keeping homeostasis, the extracellular vesicles contribute to the regulation of various systemic and local processes. Vesicles released by the tumor and activated stromal cells exhibit multiple functions including support of tumor growth, preparation of the pre-metastatic niches, and immune suppression. Considerable progress has been made regarding the criteria of classification of the vesicles according to their origin, content, and function: Exosomes, microvesicles, also referred to as microparticles or ectosomes, and large oncosomes were defined as actively released vesicles. Additionally, apoptotic bodies represented by a highly heterogeneous population of particles produced during apoptosis, the programmed cell death, should be considered. Because the majority of isolation techniques do not allow the separation of different types of vesicles, a joined term "extracellular vesicles" (EVs) was recommended by the ISEV community for the definition of vesicles isolated from either the cell culture supernatants or the body fluids. Because EV content reflects the content of the cell of origin, multiple studies on EVs from body fluids in the context of cancer diagnosis, prediction, and prognosis were performed, actively supporting their high potential as a biomarker source. Here, we review the leading achievements in EV analysis from body fluids, defined as EV-based liquid biopsy, and provide an overview of the main EV constituents: EV surface proteins, intravesicular soluble proteins, EV RNA including mRNA and miRNA, and EV DNA as potential biomarkers. Furthermore, we discuss recent developments in technology for quantitative EV analysis in the clinical setting and future perspectives toward miniaturized high-precision liquid biopsy approaches.

From biogenesis to aptasensors: advancements in analysis for tumor-derived extracellular vesicles research

Aptamer‐based extracellular vesicle isolation, analysis and therapeutics

Single Extracellular Vesicle Analysis Using Droplet Microfluidics.

Aptamer-based Isolation and Analysis Methods for Extracellular Vesicles

Analysis of extracellular vesicles as emerging theranostic nanoplatforms

Recent Progress in Isolation and Detection of Extracellular Vesicles for Cancer Diagnostics

Extracellular Vesicles: Recent Developments in Technology and Perspectives for Cancer Liquid Biopsy

Review: Multiplexed profiling of biomarkers in extracellular vesicles for cancer diagnosis and therapy monitoring

Tumor-derived extracellular vesicle proteins as new biomarkers and targets in precision oncology

Role of aptamer technology in extracellular vesicle biology and therapeutic application

Isolation and Detection Technologies of Extracellular Vesicles and Application on Cancer Diagnostic

Extracellular vesicles, the cornerstone of next-generation cancer diagnosis?

Advanced Nanotechnologies for Extracellular Vesicle‐Based Liquid Biopsy

Recent developments in biosensing methods for extracellular vesicle protein characterization

A dual aptamer recognition-based fluorescent biosensor for extracellular vesicles assays with high sensitivity and specificity

Extracellular Vesicles (evs) in Tumor Diagnosis and Therapy

Advances in extracellular vesicles analysis

Nanomaterials for Molecular Detection and Analysis of Extracellular Vesicles

Status quo of Extracellular Vesicle isolation and detection methods for clinical utility

New Technologies for Analysis of Extracellular Vesicles

Advances in Nucleic Acids-Scaffolded Electrical Sensing of Extracellular Vesicle Biomarkers